Literature DB >> 10740810

Relationship between Ras pathways and cell cycle control.

M E Ewen1.   

Abstract

The ordered execution of the two main events of cellular reproduction, duplication of the genome and cell division, characterize progression through the cell cycle. Cultured cells can be switched between cycling and non-cycling states by alteration of extracellular conditions and the notion that a critical cellular control mechanism presides on this decision, whose temporal location is known as the restriction point, has become the focus for the study of how extracellular mitogenic signalling impinges upon the cell cycle to influence proliferation. This review attempts to cover the disparate pathways of Ras-mediated mitogenic signal transduction that impact upon restriction point control.

Mesh:

Substances:

Year:  2000        PMID: 10740810     DOI: 10.1007/978-1-4615-4253-7_1

Source DB:  PubMed          Journal:  Prog Cell Cycle Res        ISSN: 1087-2957


  5 in total

Review 1.  Management of KRAS-Mutant Non-Small Cell Lung Cancer in the Era of Precision Medicine.

Authors:  Jacqueline V Aredo; Sukhmani K Padda
Journal:  Curr Treat Options Oncol       Date:  2018-06-27

2.  Germ line transmission of the Cdk4(R24C) mutation facilitates tumorigenesis and escape from cellular senescence.

Authors:  Sushil G Rane; Stephen C Cosenza; Richard V Mettus; E Premkumar Reddy
Journal:  Mol Cell Biol       Date:  2002-01       Impact factor: 4.272

3.  Role of p38 mitogen-activated protein kinase in middle ear mucosa hyperplasia during bacterial otitis media.

Authors:  Sean D Palacios; Kwang Pak; Alexander Z Rivkin; Ayse G Kayali; Darrell Austen; Christoph Aletsee; Asa Melhus; Nicholas J G Webster; Allen F Ryan
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

4.  p27Kip1 inhibition of GRB2-SOS formation can regulate Ras activation.

Authors:  Stephanie J Moeller; Elizabeth D Head; Robert J Sheaff
Journal:  Mol Cell Biol       Date:  2003-06       Impact factor: 4.272

Review 5.  Targeting CDK4 and CDK6: From Discovery to Therapy.

Authors:  Charles J Sherr; David Beach; Geoffrey I Shapiro
Journal:  Cancer Discov       Date:  2015-12-11       Impact factor: 39.397

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.